Aluminium in human tissues has been determined by flameless atomic absorption spectroscopy (AAS). Tissues were dried at l lff'C and digested with concentrated nitric acid at SO°C overnight. After dilution with distilled water the samples were measured. The aluminium levels of the controls (healthy individuals who died as a result of an accident) appeared to be: grey matter 2·1 ± 1·0 (mean±SD), white matter 1·7±0·S, spinal cord 3·3±1·S, kidney 1·9±0·7, heart 2·1±1·1, vertebral cortex 1·9±1·8, and vertebral trabeculae 3·1±1·8 Ilg/g dry weight. For a patient with dialysis motor neuropathy significantly higher values were found. Comparison with values in the literature shows that our reference values are in agreement with published results obtained by flameless atomic absorption spectroscopy.
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In patients with impaired renal function on long term haemodialysis there is hyperaluminaemia with accumulation of aluminium in various tissues. Contamination of the dialysate with aluminium and/or intestinal absorption after oral administration of aluminium-hydroxide gel are thought to be sources of increased serum and tissue aluminium.l' As a result of the aluminium accumulation patients on haernodialysis may develop dialysis encephalopathy 1-3. , and/or dialysis osteodystrophy. 4. 6 Measurement of aluminium in serum and tissue may be helpful in the understanding of cause and effect of aluminium intoxication in patients on renal dialysis. Numerous papers have been published describing assay methods and reference values for serum aluminium. Reference values for serum aluminium given in recent reports agree quite wetl.?"!" For tissue aluminium, some papersv" described elevated tissue concentrations in patients who died on long term haemodialysis. As reference material aluminium levels have been measured in healthy individuals who died as a result of an accident, I or patients who died 'Correspondence: Dr F D Posma, Streekziekenhuis Almelo, P.O. Box 5011, 7600 GA Almelo, The Netherlands. from causes other than renal failure" 6 and uraemic patients not on dialysis.v 3. , Furthermore, the analytical methods used for tissue aluminium assay are as different as flame less AAS I -4 . 6 and neutron activation analysis.'
In this study we determined tissue aluminium levels in a patient who died from motor dialysis neuropathy (a detailed description of this patient will be given elsewhere: Hoogenhuis, Posma , v d Wiel and Verhey, in preparation).
For comparison, reference values were measured in healthy individuals who died as a result of an accident.
Since comparison of our reference values for tissue aluminium with values in the literature showed substantial differences, it is the aim of this report to present a short survey of published reference values in addition to a description of our tissue aluminium assay method.
Methods
Tissue samples were obtained at necropsy within 24 h after death and stored in 10% formalin at 4°e. For aluminium assay tissue samples, about 1-2 crrr', were dissected into small pieces, rinsed twice with IS ml distilled water and dried for 4 h at 11O°e. The dried tissue was divided into four polypropylene tubes (about S0--300 mg dried tissue per tube). As described in Materials and Methods, tissues were dried for 4 h at 11O c C. Four hours appeared to be sufficient for drying, since after 2·5 h at lIQcC no further weight reduction could be obtained.
Calibration curves prepared from AICl 3 standard solutions in 0'65%-nitric acid were linear in the working range (}-50 ug/L (Figure) .
It is known that calibration graphs from aqueous standards may have a different slope in comparison with graphs from standard additions. II Therefore calibration curves were measured under various conditions, namely, standard additions, standards prepared in 0'65%-nitric acid, and standards prepared in blank solution. The calibration curves from standard additions and the standard curve prepared in blank solution appeared to be parallel. In contrast, the slope of the standard curve prepared in Q·65%-nitric acid differed from the other curves ( Figure) . This may be due to differences in nitric acid concentration or it may be ascribed to incubation at 50 cC overnight. Since we decided to calibrate by means of standard curves prepared in a blank solution these differences were not investigated further.
The sensitivity of our procedure (as defined by 4·4 milliabsorbance units) is 1·9 ug/L (corresponding to 0·5 Ilg/g dry tissue if 300 mg dry Materials Tissue aluminium levels were determined in a patient with dialysis motor neuropathy..The case history of this patient will be descnbed elsewhere (Hoogenhuis, Posma, v d Wiel and Verhey, in preparation). The control gro~p consisted of three men and three women WIth normal renal function, mean age 69 years, range 49-81 years, who died as a result of an accident.
Bouman, Platenkamp and Posma
To each tube 1 ml nitric acid suprapur (Merck) was added. One of the tubes was spiked with 1·25 ng Al (AIC1 3 in 0'65%-nitric acid as standard addition for recovery). The tubes were incubated overnight at 50 c C. After digestion the clear yellow coloured solutions were diluted with distilled water 1:36 (nitric acid concentration of the diluted samples: 1·8%). After centrifugation (2500 rpm, 10 min) the samples were analysed for their aluminium content. With each experiment two blanks (concentrated nitric acid) and two blanks spiked with 1·25 ng Al were subjected to the above procedure. Before injection, a p~rt~f. the samples or blanks was diluted 1:1 with distilled water, another part of the same sample or blank was diluted 1:1 with distilled water containing 25 Ilg/L AI. Of these solutions 20 ilL was injected. This standard addition was used as a control of the AI measurement and the results were accepted only if the recovery was within the range 80-120~o.
For standardisation a diluted AICl 3 standard solution (Titrisol, Merck) in Q·65%-nitric acid was used (concentration of AI: 25, 50, 75 and 100 ug/L, respectively). Before measurement these standard solutions were diluted 1:1 with a blank (containing 1·8% nitric acid).
The aluminium was measured by flameless AAS with a Perkin Elmer model 420 atomic absorption spectrophotometer in conjunction with a Perkin Elmer HGA 76 graphite furnace. tissue has been digested). The mean recovery of the digestion procedure was 96±10% (mean±SD, n=33), range 80-117%. The aluminium concentration in various tissues from control subjects with normal renal function and from a patient with dialysis motor neuropathy are given in Table 1 . The aluminium levels in the patient's tissue are significantly higher than those in control subjects (P<O·OO2 for white matter and P<O·OOl for the other tissue).
There is a remarkable difference between the aluminium concentration in the white and grey matter of the patient. In contrast, the aluminium levels in the white and grey matter of the control subjects are not significantly different. This is in agreement with the results of Alfrey et all and McDermott et al. 2 From the results in Table 1 it can be seen that the coefficients of variation for tissue aluminium are between 5 and 22% for the patient values. The mean coefficients of variation for the controls are: grey matter 32%, white matter 16%, spinal cord 17%, kidney 9%, heart 19%, vertebral cortex 35%, vertebral trabeculae 18%. The coefficients of variation for the control group are higher, since the aluminium content in the tissue of the control group is lower.
COMPARISON OF OUR REFERENCE VALUES FOR TISSUE ALUMINIUM WITH LITERATURE

VALUES
Since the measuring procedure for tissue aluminium used in the literature varies, and also since the composition of the control group differs from one study to another, we present a survey of the various methods and tissue aluminium levels found.
Comparing the reference values in Table 2 , it can easily be seen that our results are in good agreement with those of Alfrey et all and with those of McDermott et al. 2 • 3 Although other authors": " also used flameless AAS they found higher aluminium levels for bone; this may be due to a more complicated sample preparation. The differences cannot be ascribed to different control groups, because at least one of the authors" used non-renal patients.
Reference values for tissue aluminium found by neutron activation analysis" are higher than ours. The origin of this difference is not clear.
It is remarkable that the results of McDermott et ap· 3 for brain aluminium are similar to those of Alfrey et all and ours, notwithstanding the fact that the control groups are composed of different kinds of individuals. To our knowledge, only one report directly compares tissue aluminium levels from non-renal patients with those of patients with chronic renal insufficiency not on dialysis. Only small differences between the tissue aluminium levels of nonrenal patients and uraemic patients not on renal dialysis are found, supporting the above findings.
Conclusion
In conclusion, it can be said that our method for the determination of tissue. aluminium by flameless AAS, without the need for ashing tissues at 400°C or 600°C before extraction of aluminium in EDTA I or nitric acid." 3 works well.
We did not find sample contamination and/or erratic results after nitric acid digestion, as described by others. ' Our reference values for tissue aluminium O:l C l:: 1; voVvol) . After redrying the brain tissue was ashed at 400°C for 16 h. The dried and defatted bone and muscle and the ashed brain were extracted by a saturated EDTA solution. This solution was measured by AAS.
c Dry tissue was ashed at 6Q0 0 c. Aluminium was determined in a 9%-nitric acid solution of the ash. levels are in good agreement with other values'"? found by flameless AAS using relatively simple sample preparation. More complicated sample preparation tends to give higher values.": 6
